FA
ABBV icon

Friess Associates’s AbbVie ABBV Stock Holding History

Friess Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-85,941
Closed -$4.96M – 142
2014
Q3 		$4.96M Sell
85,941
-210,965
-71% -$11.7M 0.42% 69
2014
Q2 		$16.8M Buy
+296,906
New +$15.6M 1.37% 36

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Friess Associates's ABBV Position: Q4 2014 in Review

Friess Associates sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 85,941 shares — an estimated $4.96M sold.

Friess Associates first reported a position in ABBV in Q2 2014 and held it in 2 quarters. The position peaked at $16.8M in Q2 2014. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Friess Associates reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
  • Friess Associates sold 85,941 AbbVie shares in Q4 2014, an estimated $4.96M.
  • Friess Associates first reported a position in AbbVie in Q2 2014 and held it in 2 quarters.
  • Friess Associates's AbbVie position peaked at $16.8M in Q2 2014.
  • 1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Friess Associates's 13F filing for Q4 2014, filed 13 Feb 2015.